The Bensadoun School cordially invites you to join us for a special seminar featuring two experts on COVID-19 vaccines. Dr. Brian Ward, an infectious diseases expert and vaccine developer, will share his medical knowledge on COVID-19 vaccines, and Dr. Tinglong Dai, a healthcare analytics expert, will share his perspectives on vaccine distribution and delivery.
Friday, April 9, 2021
12:00 pm - 2:00 pm EST
Professor, Department of Medicine, Division of Experimental Medicine, McGill University
Friday, April 9, 2021
12:00 pm – 1:00 pm EST (45 min presentation, 15 min Q&A)
Dr. Brian Ward received medical training at McGill University, the University of London and Johns Hopkins (Internal Medicine, Tropical Medicine, Infectious Diseases & Microbiology). His research training began as a Rhodes scholar (1977-1980) and continued at Johns Hopkins (1986-1990). He joined the McGill medical faculty in 1991 where he is currently full professor. He has served as chief of Infectious Diseases (2002-2006), medical director of the National Reference Centre for Parasitology (1996-2018), deputy director of the MUHC Research Institute (Fundamental Science: 2008-2015), associate director of the JD MacLean Tropical Diseases Centre (1996-2018) and director of the McGill Vaccine Study Centre (1994-2020). He is currently chair of the Institutional Advisory Board for the Canadian Institutes for Health Research Institute of Infection and Immunity and is the past-chair of the Canadian Association for Immunization Research and Evaluation, a national network of >200 vaccine investigators. Since 2010, he has served as Medical Officer for Medicago Inc. His research focuses on the development of novel vaccine platforms. He has published >250 peer-reviewed manuscripts/chapters and is a fellow of the Canadian Academy of Health Sciences.
Presentation: COVID-19 Vaccines: From Concept to Vaccinating Almost 8 Billion People
Abstract: In the 15 months since the world first 'met' SARS-COV-2, this 100nM virus has killed more than 2.7 million people and cost the global economy $16-17 (USD) trillion. The development of vaccines began within days of the isolation and sequencing of SARS-COV-2 and represents the best hope for bringing some semblance of normalcy back to all of our lives. The current status and future directions of anti-COVID vaccines will be reviewed.
Associate Professor, Operations Management and Business Analytics, Johns Hopkins Carey Business School
Friday, April 9, 2021
1:00 pm – 2:00 pm EST (45 min presentation, 15 min Q&A)
Tinglong Dai is an Associate Professor of Operations Management and Business Analytics at the Johns Hopkins Carey Business School, with leadership positions at Hopkins Business of Health Initiative and Johns Hopkins Institute for Data-Intensive Engineering and Science. As an internationally renowned expert in healthcare operations management, Prof. Dai has been recognized by the Johns Hopkins Discovery Award, Wickham Skinner Early Career Award, INFORMS Public Sector Operations Research Best Paper Award, and POMS Best Healthcare Paper Award. His research has been published in leading academic journals, including Harvard Business Review, Management Science, M&SOM, Marketing Science, and Operations Research. He serves as an associate editor for M&SOM, Naval Research Logistics and Health Care Management Science, and a senior editor for Production and Operations Management. Prof. Dai has appeared in national and international TV such as CNBC, PBS NewsHour, and Sky News, and has received coverage in ABC News, AP News, Barron’s, Bloomberg, CBC, CBS News, CNBC, CNN, Fast Company, Fortune, Globe and Mail, KHN, MarketWatch, Modern Healthcare, NBC, Public Radio International, U.S. News & World Report, USA Today, Washington Post, and WIRED. Prof. Dai earned his PhD (2013) and MS (2009) in Operations Management/Robotics from Tepper School of Business, Carnegie Mellon University, in addition to an MPhil (2006) in Industrial Engineering from the Hong Kong University of Science and Technology. For more about Prof. Dai, please visit http://tinglongdai.com
Presentation: Transforming COVID-19 Vaccines into Vaccination: Challenges and Opportunities for Management Scientists
Abstract: Amid the prolonged COVID-19 pandemic, glimmers of hope have appeared via the miraculous breakthroughs of multiple effective and safe COVID-19 vaccines that were developed with record speeds. Yet, the endgame of the pandemic is not vaccines; it is vaccination. The daunting challenge of vaccinating the world offers ample investigative opportunities for management scientists who are interested in improving the efficiency and equity of healthcare systems. In this talk, I provide a broad overview of COVID-19 vaccination design and highlight a recent work comparing various vaccine rollout policies.